Signaturefd, LLC Cytokinetics Inc Transaction History

Signaturefd, LLC

$4.94 Billion
Q1 2025

A detailed history of Signaturefd, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 515 shares of CYTK stock, worth $17,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

515

Previous 464 10.99%

Holding current value

$17,061

Previous $21,000 4.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$40.19 - $51.12 $2,049 - $2,607	51 Added 10.99%	515 $20,000
Q4 2024 Feb 10, 2025	SELL	$46.36 - $58.62 $2,549 - $3,224	-55 Reduced 10.6%	464 $21,000
Q3 2024 Oct 21, 2024	SELL	$51.22 - $60.16 $2,151 - $2,526	-42 Reduced 7.49%	519 $27,000
Q2 2024 Jul 29, 2024	SELL	$47.86 - $75.05 $9,284 - $14,559	-194 Reduced 25.7%	561 $30,000
Q1 2024 May 03, 2024	BUY	$63.75 - $108.06 $21,165 - $35,875	332 Added 78.49%	755 $52,000
Q4 2023 Jan 31, 2024	SELL	$26.88 - $83.49 $860 - $2,671	-32 Reduced 7.03%	423 $35,000
Q3 2023 Nov 03, 2023	BUY	$29.46 - $36.61 $9,545 - $11,861	324 Added 247.33%	455 $13,000
Q2 2023 Aug 01, 2023	BUY	$32.62 - $40.75 $2,870 - $3,586	88 Added 204.65%	131 $4,000
Q1 2023 Apr 28, 2023	SELL	$33.36 - $45.71 $467 - $639	-14 Reduced 24.56%	43 $1,000
Q4 2022 Jan 27, 2023	BUY	$35.77 - $51.11 $107 - $153	3 Added 5.56%	57 $2,000
Q3 2022 Nov 08, 2022	SELL	$38.54 - $54.52 $655 - $926	-17 Reduced 23.94%	54 $3,000
Q2 2022 Aug 10, 2022	BUY	$33.93 - $48.92 $2,409 - $3,473	71 New	71 $3,000

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.12B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account